312 results on '"Lango, Miriam"'
Search Results
2. Head and neck surgical oncology in the time of a pandemic: Subsite‐specific triage guidelines during the COVID‐19 pandemic
3. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.
4. Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
5. ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume
6. Management of Regional Lymph Nodes in Head and Neck Melanoma
7. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis
8. Depletion of effector regulatory T cells drives major response to induction dual immune checkpoint blockade
9. Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores – A pooled analysis of RTOG 0129 and 0522
10. Surgical Management of Merkel Cell Carcinoma
11. Survivin expression and impact on head and neck cancer outcomes
12. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer
13. Diverging incidence trends for larynx and tonsil cancer in low socioeconomic regions of the US
14. The Influence of Occupation on Self-perceived Vocal Problems in Patients With Voice Complaints
15. Otolaryngology-Related Disorders in Underserved Populations, Otolaryngology Training and Workforce Considerations in North America
16. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence
17. Supplementary Figure S1 from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
18. Supplemental Tables and Figure Legends from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
19. Supplementary Table S1 from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
20. Data from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
21. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer
22. Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence
23. Supplementary Figure Legend from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
24. Supplementary Figures 1 - 2 from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
25. Supplementary Table 1 from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
26. Multi-Specialty Expert Physician Identification of Extranodal Extension in Computed Tomography Scans of Oropharyngeal Cancer Patients: Prospective Blinded Human Inter-Observer Performance Evaluation
27. Impact of Cancer Care Regionalization on Patient Volume
28. Analysis of Unmet Information Needs Among Patients With Thyroid Cancer
29. 568 Phase 2 trial of induction and concomitant CTLA4 (ipilimumab) and PD-1 (nivolumab) immune checkpoint blockade and intensity modulated radiation therapy (IMRT) in HPV-positive oropharyngeal squamous cell carcinoma (HPV-OPSCC)
30. AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer
31. Dysplasia at the margin? Investigating the case for subsequent therapy in ‘Low-Risk’ squamous cell carcinoma of the oral tongue
32. Analysis of Unmet Information Needs Among Patients With Thyroid Cancer.
33. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
34. Use of a Conventional Low Neck Field (LNF) and Intensity-Modulated Radiotherapy (IMRT): No Clinical Detriment of IMRT to an Anterior LNF During the Treatment of Head-and Neck-Cancer
35. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation
36. Initial Results of a Phase I Dose-Escalation Trial of Concurrent and Maintenance Erlotinib and Reirradiation for Recurrent and New Primary Head-and-Neck Cancer
37. Multimodal Treatment for Head and Neck Cancer
38. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary
39. Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311).
40. Informational needs of head and neck cancer patients
41. Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer
42. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer
43. Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns
44. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: The Fox Chase Cancer Center experience
45. BIOBEHAVIORAL PATHWAYS IN HEAD AND NECK CANCER: Paper Session 02 2:00 PM-2:18 PM 2051
46. Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome
47. Effect of Sentinel Lymph Node Biopsy and LVI on Merkel Cell Carcinoma Prognosis and Treatment
48. Abstract B40: Trends in lymph node yield for neck dissection and oral cavity carcinoma survival
49. What the thyroid cancer patient wants to know: ThyCa survey by the American Head and Neck Society Endocrine Surgery Section
50. Heat and moisture exchanger cassettes: Results of a quality/safety initiative to reduce postoperative mucus plugging after total laryngectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.